Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by lscfaon Oct 28, 2022 3:50pm
87 Views
Post# 35056736

RE:RE:RE:SIRONAINVESTOR

RE:RE:RE:SIRONAINVESTORThey won't even tell us why no revenues from R+F for last 3 qtrs.    
bealert wrote: I apologize for being narrow sighted as I thought that was the main subject.

As far as Howhee goes, I doubt you could ever get him into  long Q & A with shareholders as he would lose control so fast that it would most likely be a big fumble session.  When he is one on one with the camera, they already have the subject matter pre-determined so he can give out his pre-determined answers,  Unfortunately I do not believe reality and responsibility would be well served if he were to host a Q &A session.  If I thought it would be otherwise, we probably would already be $1 + and we would be having a different conversation.

The only way forward is to have a CEO who will 'face the music' and remain in control of everything.

BeAlert


<< Previous
Bullboard Posts
Next >>